日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination therapy of an 211At-labeled RGD peptide and immune checkpoint blockade to enhance antitumor efficacy

211At标记的RGD肽与免疫检查点阻断剂联合治疗可增强抗肿瘤疗效

Hiroaki Echigo,Masayuki Munekane,Takeshi Fuchigami,Kohshin Washiyama,Takashi Nakamura,Atsushi Furukawa,Zhuoqing Chen,Kenji Mishiro,Hiroshi Wakabayashi,Kazuhiro Takahashi,Seigo Kinuya,Kazuma Ogawa

Preparation and Evaluation of Radiolabeled Porphyrin-Functionalized Lipid Nanodroplets for Cancer Theranostics

制备和评价放射性标记卟啉功能化脂质纳米液滴在癌症诊疗中的应用

Ramzi, Nur Izni Binti; Tamamura, Kisa; Munekane, Masayuki; Mishiro, Kenji; Fuchigami, Takeshi; Hu, Xiaojun; Jastrząb, Renata; Kinuya, Seigo; Ninomiya, Kazuaki; Ogawa, Kazuma

ABCC6 pathogenic variants are associated with hemorrhagic phenotypes in Japanese patients with severe cerebral small vessel disease

ABCC6致病变异与日本重度脑小血管病患者的出血表型相关

Kitahara, Sho; Ando, Shoichiro; Uemura, Masahiro; Hatano, Yuya; Nozaki, Hiroaki; Hirozawa, Daisuke; Nomura, Emi; Okubo, Kohei; Munekane, Asami; Tashiro, Takumi; Asai, Kanako; Yamaoka, Minako; Taneda, Tomone; Honma, Yutaka; Kondo, Hajime; Itabashi, Ryo; Iwanaga, Akira; Murota, Hiroyuki; Aizawa, Hitoshi; Ishihara, Tomohiko; Onodera, Osamu

Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics

利用白蛋白结合竞争剂构建具有白蛋白结合部分的放射性杂合PSMA配体,并通过其药代动力学调控实现放射性诊疗

Hirata, Saki; Echigo, Hiroaki; Munekane, Masayuki; Mishiro, Kenji; Washiyama, Kohshin; Fuchigami, Takeshi; Wakabayashi, Hiroshi; Takahashi, Kazuhiro; Kinuya, Seigo; Ogawa, Kazuma

Synthesis and Evaluation of Radiogallium-Labeled Peptide Probes for In Vivo Imaging of Legumain Activity

合成和评价放射性镓标记肽探针用于体内成像半胱氨酸蛋白酶活性

Fuchigami, Takeshi; Itagaki, Kohnosuke; Yoshida, Sakura; Nakayama, Morio; Munekane, Masayuki; Ogawa, Kazuma

Development of a Theranostic Agent for Bone Metastases: Integration of Nuclear Medicine Imaging and Boron Neutron Capture Therapy (BNCT)

骨转移瘤诊疗一体化药物的研发:核医学成像与硼中子俘获疗法(BNCT)的整合

Kisa Tamamura,Yuito Akita,Kenji Mishiro,Masayuki Munekane,Takeshi Fuchigami,Yoshiki Fujikawa,Hiroshi Wakabayashi,Fuko Ikoma,Xiaojun Hu,Shinji Kawabata,Seigo Kinuya,Minoru Suzuki,Kazuma Ogawa

Correction: Recent advances in the development of (225)Ac- and (211)At-labeled radioligands for radiotheranostics

更正:用于放射诊疗的 (225)Ac 和 (211)At 标记放射性配体的最新进展

Munekane, Masayuki; Fuchigami, Takeshi; Ogawa, Kazuma

Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

通过施用白蛋白结合抑制剂来优化带有白蛋白结合部分的 211At 标记的 RGD 肽的药代动力学

Hiroaki Echigo,Masayuki Munekane,Takeshi Fuchigami,Kohshin Washiyama,Kenji Mishiro,Hiroshi Wakabayashi,Kazuhiro Takahashi,Seigo Kinuya,Kazuma Ogawa

Peptide-Based Turn-On Fluorescent Probes for Highly Specific Detection of Survivin Protein in the Cancer Cells

基于肽的荧光探针可高特异性检测癌细胞中的Survivin蛋白

Fuchigami, Takeshi; Nakayama, Tomoe; Miyanari, Yusuke; Nozaki, Iori; Ishikawa, Natsumi; Tagawa, Ayako; Yoshida, Sakura; Munekane, Masayuki; Nakayama, Morio; Ogawa, Kazuma

Differences in the Renal Accumulation of Radiogallium-Labeled (Glu)14 Peptides Containing Different Optical Isomers of Glutamic Acid

含有不同谷氨酸光学异构体的放射性镓标记的(Glu)14肽在肾脏中的蓄积差异

Kazuma Ogawa,Kota Nishizawa,Kenji Mishiro,Masayuki Munekane,Takeshi Fuchigami,Hiroaki Echigo,Hiroshi Wakabayashi,Seigo Kinuya